These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27518913)

  • 1. Role of CFTR variants explored in developing cystic fibrosis symptoms: Latest research highlights disease manifestations in diverse ethnicities of children.
    Am J Med Genet A; 2016 Sep; 170(9):2233-4. PubMed ID: 27518913
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency of intron 8 CFTR polythymidine sequence variant in neonatal blood specimens.
    Chin S; Ranieri E; Gerace RL; Nelson PV; Carey WF
    Lancet; 1997 Nov; 350(9088):1368-9. PubMed ID: 9365460
    [No Abstract]   [Full Text] [Related]  

  • 3. Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California.
    Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
    PLoS One; 2016; 11(5):e0155624. PubMed ID: 27214204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
    Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
    Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn cystic fibrosis screening in southeastern Mexico: Birth prevalence and novel CFTR gene variants.
    Ibarra-González I; Campos-Garcia FJ; Herrera-Pérez LDA; Martínez-Cruz P; Moreno-Graciano CM; Contreras-Capetillo SN; León-Burgos V; Maldonado-Solis FA; Alcántara-Ortigoza MA; González Del Angel A; Vela-Amieva M
    J Med Screen; 2018 Sep; 25(3):119-125. PubMed ID: 28992757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory tests for the diagnosis of cystic fibrosis.
    Wang L; Freedman SD
    Am J Clin Pathol; 2002 Jun; 117 Suppl():S109-15. PubMed ID: 14569807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants.
    Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
    J Cyst Fibros; 2015 Nov; 14(6):714-9. PubMed ID: 25824995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
    Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
    J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Low-Cost and Simple Genetic Screening for Cystic Fibrosis Provided by the Brazilian Public Health System.
    Rispoli T; Martins de Castro S; Grandi T; Prado M; Filippon L; Dornelles da Silva CM; Vargas JE; Rossetti LMR
    J Pediatr; 2018 Aug; 199():272-277.e3. PubMed ID: 29731357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic Fibrosis Diagnosis and Newborn Screening.
    Rosenfeld M; Sontag MK; Ren CL
    Pediatr Clin North Am; 2016 Aug; 63(4):599-615. PubMed ID: 27469178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cystic fibrosis and neonatal screening].
    Nau JY
    Rev Med Suisse; 2007 May; 3(110):1212. PubMed ID: 17564353
    [No Abstract]   [Full Text] [Related]  

  • 12. Cystic fibrosis newborn screening: shifting the key question from "should we screen?" to "how should we screen?".
    Farrell PM
    Pediatrics; 2004 Jun; 113(6):1811-2. PubMed ID: 15173512
    [No Abstract]   [Full Text] [Related]  

  • 13. Spectrum of CFTR mutations on Réunion Island: impact on neonatal screening.
    Bienvenu T; Viel M; Leroy C; Cartault F; Lesure JF; Renouil M
    Hum Biol; 2005 Oct; 77(5):705-14. PubMed ID: 16596947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False negative cystic fibrosis newborn screen.
    Collaco JM; Panny SR; Hamosh A; Mogayzel PJ
    Clin Pediatr (Phila); 2010 Mar; 49(3):214-6. PubMed ID: 20164071
    [No Abstract]   [Full Text] [Related]  

  • 15. New cystic fibrosis genetic tests bring hope and dilemmas.
    Arnold C
    Lancet Respir Med; 2014 Jan; 2(1):30. PubMed ID: 24461897
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenatal and newborn screening for CFTR mutations: the difficulties of prediction.
    Schwarz MJ
    Clin Biochem; 2011 May; 44(7):485-486. PubMed ID: 22036338
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular Genetics of Cystic Fibrosis Transmembrane Conductance Regulator: Genotype and Phenotype.
    Sosnay PR; Raraigh KS; Gibson RL
    Pediatr Clin North Am; 2016 Aug; 63(4):585-98. PubMed ID: 27469177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and clinical features of false-negative infants in a neonatal screening programme for cystic fibrosis.
    Padoan R; Genoni S; Moretti E; Seia M; Giunta A; Corbetta C
    Acta Paediatr; 2002; 91(1):82-7. PubMed ID: 11883825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.
    Mickle JE; Cutting GR
    Clin Chest Med; 1998 Sep; 19(3):443-58, v. PubMed ID: 9759548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An innovative strategy for personalised medicine in a CFSPID case that evolved with time.
    Twynam-Perkins J; Fall A; Lefferts JW; Urquhart DS
    Paediatr Respir Rev; 2023 Sep; 47():23-26. PubMed ID: 37407313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.